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Abstract
Background: Microarray analyses based on differentially expressed genes (DEGs) have been widely used to
distinguish samples across different cellular conditions. However, studies based on DEGs have not been able to
clearly determine significant differences between samples of pathophysiologically similar HIV-1 stages, e.g.,
between acute and chronic progressive (or AIDS) or between uninfected and clinically latent stages. We here
suggest a novel approach to allow such discrimination based on stage-specific genetic features of HIV-1
infection. Our approach is based on co-expression changes of genes known to interact. The method can
identify a genetic signature for a single sample as contrasted with existing protein-protein-based analyses with
correlational designs.
Methods: Our approach distinguishes each sample using differentially co-expressed interacting protein pairs
(DEPs) based on co-expression scores of individual interacting pairs within a sample. The co-expression score
has positive value if two genes in a sample are simultaneously up-regulated or down-regulated. And the score
has higher absolute value if expression-changing ratios are similar between the two genes. We compared
characteristics of DEPs with that of DEGs by evaluating their usefulness in separation of HIV-1 stage. And we
identified DEP-based network-modules and their gene-ontology enrichment to find out the HIV-1 stage-specific
gene signature.
Results: Based on the DEP approach, we observed clear separation among samples from distinct HIV-1 stages
using clustering and principal component analyses. Moreover, the discrimination power of DEPs on the samples
(70–100% accuracy) was much higher than that of DEGs (35–45%) using several well-known classifiers. DEP-based
network analysis also revealed the HIV-1 stage-specific network modules; the main biological processes were
related to “translation,”“ RNA splicing,”“ mRNA, RNA, and nucleic acid transport,” and “DNA metabolism.” Through
the HIV-1 stage-related modules, changing stage-specific patterns of protein interactions could be observed.
Conclusions: DEP-based method discriminated the HIV-1 infection stages clearly, and revealed a HIV-1 stage-
specific gene signature. The proposed DEP-based method might complement existing DEG-based approaches in
various microarray expression analyses.
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Human immunodeficiency virus type 1 (HIV-1) has
been demonstrated to damage the human immune sys-
tem, finally leading to acquired immunodeficiency syn-
drome (AIDS), which is characterized by vulnerability to
life-threatening opportunistic infections. The natural
progression of HIV-1 consists of the acute stage, the
clinical latency stage, and AIDS [1]. The acute stage
(Acute), the first stage of HIV-1 infection, results from
contamination with the HIV-1 virus through body fluids
such as blood, semen, or vaginal fluid. In this stage, the
copy number of HIV-1 virus rapidly increases, and the
number of CD4+ T cells markedly decreases [2]. How-
ever, most patients with HIV-1 infection recover from
the acute stage without treatment within 3 to 6 weeks
and have a period of clinical latency of 8 to 10 years [1].
Although there are no clinical manifestations and the
CD4+ T-cell count is almost recovered during the clini-
cal latency stage, it has been reported that immune
damage persistently occurs [3]. Among the HIV-infected
population, approximately 5 to 8% of patients remain
clinically stable for decades. They have been referred to
as long-term non-progressors (Non-progressive)[ 4 ] .
However, most patients undergo chronic progressive
infection (Chronic) that finally leads to AIDS, at which
point the CD4+ T-cell count drops below 200 cells/μL,
and T cell-mediated immunity fails to protect the body
from pathogens.
Several studies have attempted to reveal the mechan-
ism of HIV-1 pathogenesis at the genomic level using
microarray experiments. Using analysis of differentially
expressed genes (DEGs) across HIV-1 infection stages,
Hyrcza et al. found that expression of interferon-stimu-
lated genes is increased in the early and chronic pro-
gressive stages [5]. Li et al., by a similar DEG-based
analysis using lymphatic tissue microarrays, showed that
each stage has relatively different gene expression pat-
terns [6]. These studies have enhanced our knowledge
about the pathogenic mechanism of HIV-1. One of the
common limits of these studies, however, is that DEG-
based expression analysis cannot identify an HIV-1
stage-specific gene signature that can clearly discrimi-
nate pathophysiologically similar stages, such as between
Acute and Chronic stages or between Uninfected and
Non-progressive stages [5,6].
Recently, protein-interaction-based analyses with cor-
relational designs have been successfully applied to dis-
cover a discriminant genetic signature for a specific
condition, but not for an individual sample, using
microarray analysis [7,8]. These analyses usually have
different assigned weights for an interacting protein pair
based on degrees of correlation of expression levels
under specific conditions. Genes or gene products do
not work alone, but rather function in relationship with
other genes or proteins in a real molecular setting [9].
Moreover, the degree of correlation between members
of an interacting protein pair under a specific condition
might provide evidence for the degree of functional rela-
tionship under that condition. However, this approach
requires multiple samples under a target condition to
extract the genetic features for the condition; thus, it
cannot be used for a genetic signature of a single sam-
ple, which is required to validate or test whether a new
sample has a signature similar to those of other samples
in a certain group.
Here, we suggest a novel protein-interaction-based
method to capture a genetic signature for a single sam-
ple under a specific condition. To achieve this purpose,
we assigned a co-expression (or co-changing) score to a
protein–protein interaction by comparing the expres-
sion-change ratios of the two genes in a sample with
representative values. After assigning co-expression
scores for each sample, we found differentially co-
expressed interacting protein pairs (DEPs) among condi-
tions for a condition-specific signature. We applied the
DEP-based method to samples representing the clinical
stages of HIV-1 infection to discover an HIV-1 stage-
specific signature.
Methods
Acquisition of HIV-1-infected gene expressions and
human protein–protein interactions
For HIV-1 expression data, we downloaded the Series
GSE6740 dataset from the GEO database (http://www.
ncbi.nlm.nih.gov/geo). The dataset contains stage-specific
gene expressions of CD4+ and CD8+ cells from a cohort
of HIV-infected individuals [5]. The HIV-infected indivi-
duals had not been treated at the time samples were
obtained. The profiles of CD4+ and CD8+ T cells from
individuals with early HIV-1 infections (Acute), non-pro-
gressive HIV-1 infections with low or undetectable viral
loads (Non-progressive), chronic progressive HIV-1 infec-
tions (Chronic), and uninfected individuals (Uninfected)
were selected (Figure 1A). The expression profiles were
normalized using a quantile normalization method
implemented in MATLAB R2009b (Mathworks, Natick,
MA, USA) (Figure 1B). Final expression datasets con-
tained 10 Acute,1 0Non-progressive,1 0Chronic samples,
and 10 Uninfected samples. For human protein–protein
interactions (PPIs), we used the data of Lee et al. [10],
which incorporated public databases such as DIP [11],
BIND [12], HPRD [13], and REACTOME [14]. The data
set also included the results of several recent genome-
wide studies [15-18]. A total of 80 970 interactions
among 10 819 human proteins were prepared. For the
subsequent analyses, including calculating co-expression
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acting protein pairs, only these interactions were
considered.
Calculating a co-expression score between two
interacting gene products
A co-expression (or co-changing) score between two
interacting gene products in a sample was calculated by
following two steps (Figure 1C). First, expression-chan-
ging ratios (g)o ft w og e n e s ,a and b, were defined as
follows:
gg a
X
b
Y
X
R
Y
R
== log log , 22  and 
where X (or Y) indicates the normalized expression
level of gene a (or b), and RX (or RY)i sar e p r e s e n t a t i v e
expression level of gene a (or b). In this study, the med-
ian value of expressions across samples was used as a
representative value of a specific gene. Next, a co-
expression score (r) between the two interacting gene
products in the sample was calculated using the follow-
ing equation:
Figure 1 Study overview. After acquiring expression data from gene expression omnibus (A, B), differentially expressed genes (DEGs) and
differentially expressed gene pairs (DEPs) were selected and evaluated for usefulness (C–E). The results of network analysis determined the HIV-
related network modules (F, G).
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where Min (p, q)o rMax (p, q) indicates the mini-
mum or maximum value between p and q, respectively,
and sign (x) indicates the sign of x. Note that the co-
expression score r has a positive value if X and Y are
simultaneously greater (or smaller) than RX and RY;
otherwise, it has a negative value. Moreover, the co-
expression score r has a higher absolute value if the
absolute values of expression-changing ratios are similar
between the two genes.
Identifying DEPs and DEGs
To identify DEPs for HIV-1 infection, analysis of var-
iance (ANOVA) and geometric means of differences
between median co-expression scores across individual
stages were used (Figure 1D). An interaction with a
high value of -log10(p-value of an ANOVA test) × (geo-
metric mean of differences of median co-expression
scores) was considered significant, and interactions with
higher degrees of significance than a specific cutoff
value were selected as DEPs. A similar process was
applied to select DEGs, exceptt h a te x p r e s s i o nl e v e l s ,
not co-expression scores, were used. To ensure a
balanced comparison, the most highly significant DEGs
were selected in a quantity equal to the number of
genes. Here, several values from 0.5 to 1 were examined
to identify the optimal cutoff value that provided the
smallest number of DEPs and DEGs with the best
accuracy.
PCA, clustering, and classification analyses of DEPs and
DEGs
To estimate how DEPs reveal HIV-1 stage-specific char-
acteristics, principal-component analysis (PCA) and sev-
eral well-known classification and clustering methods
were used (Figure 1E). PCA transforms attribute values
into new ones to create the linear projection of the data
that accounts for the most variance in a low-dimen-
sional subspace. Therefore, it provides snapshots of data
that we can see at a glance. Global views of DEPs were
compared with those of whole genes and DEGs using
PCA. PCA was performed using the algorithm imple-
mented in MATLAB, R2009b (MathWorks, Natick, MA,
USA).
For clustering, we used hierarchical clustering (HCL)
with the K-means methods implemented in MEV4.0
(Multiple Experiment Viewer, http://www.tm4.org) [19].
The HCL method groups samples according to the
degree of similarity between them based on feature
information (here, DEPs or DEGs) without considering
the class information (here, the HIV-1 stages).
Therefore, it was possible to confirm whether the
selected feature information of samples (i.e., DEPs or
DEGs) is valuable for clustering samples according to
stage. K-means clustering, like HCL, is an unsupervised
learning method. However, K-means clustering was used
to partition DEPs (or DEGs) into some number of clus-
ters. Here, DEPs were clustered into six groups in each
cell type (CD4+ and CD8+ cells). Stage-specific clusters
in both CD4+ and CD8+ cells were then further charac-
terized through GO term analysis.
For classification methods, we used the J48 decision
tree, the SMO support-vector machine, and the multi-
layer perception artificial neural network, which were
implemented in WEKA, version 3.6.3 [20]. Leave-one-
out cross-validation (LOOCV) using these methods was
applied to estimate the classification performance of
selected DEPs (or DEGs) for predicting the disease
stages of HIV-1. LOOCV is one of the most popular
validation methods; it trains prediction models using all
samples except one and then tests the models with the
remaining sample. This step then passes through as
many iterations as there are samples [21]. For perfor-
mance measures, we used accuracy, sensitivity, and spe-
cificity from a confusion matrix.
DEP-based network-module identification
To discover HIV-related interaction sub-networks, the
prepared PPIs and the list of genes in DEPs were
imported into Cytoscape (http://www.Cytoscape.org)
[22] with the median co-expression score for each stage
(Figure 1F). Next, we included the genes that directly
interacted with the genes in DEPs. Using the extended
network, MCODE was used to find sets of genes located
a tt h ea r e ao fd e n s eD E P s( Figure 1G). MCODE is a
Cytoscape plug-in and is one of the most popular meth-
ods by which to find highly interconnected regions in a
network [23]. The score of a sub-network was calculated
based on the complexity and density of the network.
The top 10 modules with the highest network scores
were considered significant since modules with higher
network scores showed higher prediction accuracies in
previous study [23]. Among 10 significant modules, five
modules containing DEPs were finally selected because
none of the other five modules included any DEP. Note
that a DEP in each sample has its own co-expression
score. To find a representative HIV-related module
under a specific stage, thus, we used a median value of
multiple co-expression scores for an interaction and a
median expression level for a protein, respectively.
Gene-ontology enrichment analysis
For the gene list in DEPs and DEGs, a functional annota-
tion tool called the Database for Annotation, Visualization
and Integrated Discovery (DAVID) [24] was applied to find
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test to determine whether the proportion of selected genes
falling into each category differs from the baseline (here, all
genes of Homo sapiens). For selected modules, BiNGO (the
Biological Networks Gene-ontology tool) [25] was also used
to conduct gene-ontology (GO) enrichment analysis.
BiNGO, which is implemented as a plug-in for Cytoscape,
maps the predominant functional themes of a given gene
set on the GO hierarchy and outputs this mapping as a
Cytoscape graph. Hypergeometric distribution was adopted
to find a functional degree of overrepresentation of an
HIV-related module using this method.
Results
Identifying DEPs across HIV-1 stages
We prepared 10 Acute,1 0Non-progressive,1 0Chronic
samples, and 10 Uninfected samples of CD4+ and CD8+
cells from a cohort of HIV-infected individuals (Methods).
For human protein-protein interactions, we used the data
of Lee et al. [10], which cover 80 970 interactions among
10 819 proteins. To identify DEPs, we first calculated a co-
expression score of each interaction using expression-
changing ratios of the corresponding two proteins. After
that, we found significantly different pairs using analysis of
variance (ANOVA) and geometric means of differences of
median levels across HIV-1 stages. Among 80 970 inter-
acting protein pairs, 100 pairs were selected as significant
DEPs which consist of 177 proteins across HIV-1 infection
(Table 1). A DEG-based analysis, on the other hand,
selected a different set of 177 genes: only eight genes (or
their corresponding encoding proteins) were common to
DEPs and DEGs. Figures 2A and 2B show some cases of
the selected DEPs in which DEPs could differentiate
between pathophysiologically similar HIV-1 stages. For
example, the co-expression pattern, illustrated by the line
in the figure, between HNRNPM (heterogeneous nuclear
ribonucleoprotein M, known to influence pre-mRNA pro-
cessing and other aspects of mRNA metabolism and trans-
port) and DHX9 (DEAH (Asp-Glu-Ala-His) box
polypeptide 9, known to be involved in the expression and
nuclear export of retroviral RNAs and also known to
interact with HIV-1 RNA) was positively related to the
Acute stage, whereas it was negatively related to Chronic
stage (Figure 2A). However, a DEG-based analysis missed
the HIV-1 related proteins HNRNPM and DHX9 because
of the similar median expression levels across the Acute
(black “+”) and Chronic (black dashed “×”) stages. A simi-
lar phenomenon was observed between LRRC1 (leucine-
rich repeat containing 1) and SIAH2 (seven in absentia
homolog 2, known to be involved in ubiquitination and
proteasome-mediated degradation) which were positive in
Uninfected but negative in Non-progressive stages, whereas
the median expression levels of LRRC1 and SIAH2 were
similar between the two stages (Figure 2B).
The functional characteristics were also significantly
different between DEPs and DEGs (Figure 2C). The
number of enriched GO terms using the 177 proteins of
DEPs was 49, whereas it was 21 in the case of DEGs
(the GO terms with >10 genes/proteins and p-value of
<1.0×10
–5 using DAVID tools). Among the enriched
GO terms, 13 overlapped and were mainly associated
with “translation” biological processes. Thirty-six GO
terms included only in DEPs were related to responses
against endogenous or exogenous stimuli (from tran-
scription to mRNA processing). They were particularly
associated with apoptosis (“positive regulation of apop-
tosis”, “positive regulation of programmed cell death”,
and “positive regulation of cell death”), which is known
to be an important factor in the progression of HIV by
the resulting depletion of T helper cells [26]. On the
other hand, the GO terms only for DEGs included
“response to virus” and “immune response”.
PCA results of DEPs and DEGs of HIV-1
We applied PCA to evaluate the geometric view of the
samples in various HIV-1 stages with i)w h o l eg e n e so ft h e
microarray, ii)t h ei d e n t i f i e dD E G s ,o riii)t h ei d e n t i f i e d
DEPs (Figure 3). In the case of whole genes (Figure 3A),
the four areas of samples in distinct HIV-1 stages highly
overlapped one another with regard to the first three prin-
cipal components, even though the samples were separ-
able according to cell type (CD4+ cells in red and CD8+
cells in blue). In the PCA analysis with DEGs (Figure 3B),
the HIV-1 stages were still not separable; in particular, the
Uninfected and Non-progressive areas and the Acute and
Chronic areas were highly overlapped. When the identified
DEPs were used (Figure 3C), however, all four stages were
clearly separable using the three components, regardless of
cell type. Interestingly, pathophysiologically similar HIV-1
stages, such as Acute and Chronic or Uninfected and Non-
progressive, were highly discriminable using the first two
principal components (middle panel of Figure 3C),
although there was an area that overlapped between
Chronic and Non-progressive. These four stages were
clearly separable both in the first and third planes and in
the second and third planes (first and third panels of Fig-
ure 3C, respectively). This tendency was also observed in
individual cell types, i.e., in CD4+ cells and CD8+ cells.
The DEP PCA results showed the most clearly discrimi-
nated distribution of the samples across the HIV-1 stages
compared with those of whole genes or DEGs regardless
of cell type.
Clustering results of DEPs in HIV-1
We applied clustering methods to the samples without
seeing their HIV-1 stage information. When the
extracted DEG-based features were used for the indivi-
dual CD4+ samples (Figure 4A), the samples were
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cially between Acute and Chronic (in orange and red,
respectively) and between Non-progressive and Unin-
fected (in blue and green, respectively). This indicates
that Chronic samples and Acute samples have similar
expression patterns, as do Non-progressive and Unin-
fected stages. When DEP-based features were used with
the same hierarchical clustering method, however,
same-stage samples were clustered first (Figure 4B).
After grouping samples according to stage information,
Chronic and Non-progressive samples were then clus-
tered. Finally, Uninfected and Acute were clustered in
sequence. The heat maps of hierarchical clustering
results showed that the co-expression patterns of each
Table 1 Protein pairs included in the top-30 DEPs
Protein 1 Name of Protein 1 Protein 2 Name of Protein 2 P-value G-mean Significance
NUTF2 nuclear transport factor 2 NUP62 nucleoporin 62kDa 7.5E-06 0.37 1.90
CDC7 cell division cycle 7 homolog (S. cerevisiae) MCM3 minichromosome maintenance complex
component 3
1.3E-05 0.34 1.66
VAMP1 vesicle-associated membrane protein 1
(synaptobrevin 1)
ARFGAP1 ADP-ribosylation factor GTPase activating
protein 1
4.3E-05 0.36 1.56
HSPA8 heat shock 70kDa protein 8 TADA3L transcriptional adaptor 3 1.0E-05 0.26 1.29
TNR tenascin R (restrictin, janusin) NFASC neurofascin 1.6E-04 0.33 1.25
ARHGEF2 Rho/Rac guanine nucleotide exchange
factor (GEF) 2
PRKCI protein kinase C, iota 6.4E-05 0.28 1.17
PDGFRB platelet-derived growth factor receptor,
beta polypeptide
SNX2 sorting nexin 2 8.7E-05 0.28 1.14
RFC5 replication factor C (activator 1) 5, 36.5kDa POLA1 polymerase (DNA directed), alpha 1,
catalytic subunit
5.5E-05 0.27 1.13
NFIB nuclear factor I/B RFX1 regulatory factor X, 1 (influences HLA class
II expression)
3.4E-04 0.32 1.12
EIF3I eukaryotic translation initiation factor 3,
subunit I
SUMO4 SMT3 suppressor of mif two 3 homolog 4
(S. cerevisiae)
1.7E-05 0.23 1.09
COL17A1 collagen, type XVII, alpha 1 LAD1 ladinin 1 3.9E-04 0.31 1.07
IRS1 insulin receptor substrate 1 UBTF upstream binding transcription factor, RNA
polymerase I
4.5E-04 0.32 1.05
CAV1 caveolin 1, caveolae protein, 22kDa TRAF6 TNF receptor-associated factor 6 1.0E-04 0.26 1.05
RPS14 ribosomal protein S14 RPS27A ribosomal protein S27a 3.2E-03 0.41 1.03
HNRNPA2B1 heterogeneous nuclear ribonucleoprotein
A2/B1
HNRNPH1 heterogeneous nuclear ribonucleoprotein
H1 (H)
4.1E-05 0.23 1.02
TAF4 TATA box binding protein (TBP)-associated
factor, 135kDa
CBX3 chromobox homolog 3 1.0E-03 0.34 1.01
VPS11 vacuolar protein sorting 11 homolog (S.
cerevisiae)
VPS45 vacuolar protein sorting 45 homolog (S.
cerevisiae)
2.4E-04 0.28 1.00
ATP5F1 ATP synthase, H+ transporting,
mitochondrial Fo complex, subunit B1
ATP5J2 ATP synthase, H+ transporting,
mitochondrial Fo complex, subunit F2
8.1E-05 0.24 0.99
POLR2G polymerase (RNA) II (DNA directed)
polypeptide G
SF3B2 splicing factor 3b, subunit 2, 145kDa 2.6E-03 0.38 0.98
PDPK1 3-phosphoinositide dependent protein
kinase-1
PRKCQ protein kinase C, theta 4.5E-05 0.22 0.97
EP300 E1A binding protein p300 TF transferrin 5.3E-04 0.30 0.97
RPS5 ribosomal protein S5 RPL28 ribosomal protein L28 1.4E-03 0.34 0.96
ELK1 ELK1, member of ETS oncogene family GRB10 growth factor receptor-bound protein 10 9.7E-04 0.32 0.96
RPS13 ribosomal protein S13 ATAD3A ATPase family, AAA domain containing 3A 5.8E-05 0.23 0.95
PABPC1 poly(A) binding protein, cytoplasmic 1 RPS4Y1 ribosomal protein S4, Y-linked 1 2.5E-03 0.37 0.95
PRPF4 PRP4 pre-mRNA processing factor 4
homolog (yeast)
PPIH peptidylprolyl isomerase H (cyclophilin H) 6.5E-04 0.29 0.93
ZFP36 zinc finger protein 36, C3H type, homolog
(mouse)
EIF2C4 eukaryotic translation initiation factor 2C, 4 6.3E-04 0.29 0.93
RPLP2 ribosomal protein, large, P2 RPL29 ribosomal protein L29 1.2E-03 0.32 0.93
HSF1 heat shock transcription factor 1 STIP1 stress-induced-phosphoprotein 1 1.5E-04 0.24 0.92
GSK3B glycogen synthase kinase 3 beta FUS fused in sarcoma 2.7E-03 0.35 0.91
Here, significance is “-log(P-value) × G-mean”.
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whereas individual gene expression patterns lacked dis-
tinct patterns according to stage, especially between
pathophysiologically similar HIV-1 stages (e.g., between
Acute and Chronic or between Uninfected and Non-pro-
gressive stages). This tendency was also observed in
CD8+ cells. Moreover, the DEP-based features clearly
clustered each stage of HIV-1, regardless of cell type.
Co-expression patterns of samples were preserved
across individual HIV-1 stages.
To discover stage-specific co-expressed pairs, we next
clustered the 100 identified DEPs into six groups using
a K-means clustering method. Different cell types might
be associated with different DEP groups; therefore, we
identified separate clusters using only CD4+ samples or
only CD8+ samples. Of the six groups, four groups in
each cell type showed stage-specific co-expression pat-
terns. Surprisingly, the median co-expression scores of
groups across samples were quite similar between CD4+
and CD8+ cells. Moreover, each pair of groups with a
similar co-expression pattern shared many DEPs. Using
the DEPs shared between CD4+ and CD8+ cells, we
analyzed enriched GO terms (Figure 4C). Common bio-
logical functions of all four clusters were “RNA splicing”
Figure 2 Comparison of DEPs and DEGs. (A, B) Expressions and correlations of DEPs. The X-a n dY-axes represent expression levels of each
gene. Expression levels of the samples are represented by dots (X, Uninfected (UI); O, Acute (AT); *, Non-progressive (NP); +, Chronic (CN)). Median
values of samples in the same stage are marked with bigger black “+” and “×”. Trend lines are shown with degrees of correlation. (C) Gene-
ontology (GO) enrichment analysis of DEPs and DEGs. The numbers in circles indicate the counts of GO terms relevant to DEPs, DEGs, or both.
Precise details and their -log10 p values are listed next to the numbers.
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composed of 14 DEPs, had lower co-expression scores
only in the Uninfected stage. The genes of the 14 DEPs
a r ek n o w nt op l a yam a j o rr o l ei n“transcription” in
addition to the common functions. In contrast, the
second cluster, which had 10 DEPs with lower co-
expression scores only in the Acute stage, was involved
in “translation” rather than “transcription”. The genes in
the seven DEPs of the third cluster, which had higher
co-expression scores only in the Non-progressive stages,
Figure 3 Result of principal-component analysis. (A) Global view of all expression data sets using principal component analysis. The first
principal component accounts for as much variability in the expression of total genes as possible. The second and third components account
for as much of the remaining variability as possible. Results of principal component analysis with DEGs and DEPs are shown in (B) and (C),
respectively.
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Page 8 of 14Figure 4 Clustering results using DEPs and DEGs. (A) Heat map for expression of DEGs across the samples. Each lane represents the
expression profile of one sample. Result of hierarchical clustering with DEGs is shown at the top of the heat map (UI, Uninfected; AT, Acute; NP,
Non-progressive; CN, Chronic). (B) Heat map for co-expressed score of DEPs. (C) Four representative clusters of gene pairs. Of six groups of gene
pairs clustered by K-means clustering using Pearson’s correlation between pairs and samples, four groups had relatively different co-expression
scores compared with the other stages. The X-axis represents samples, and the Y-axis represents co-expression score. The top 10 GO terms
related to biological processes are listed in descending order of p-values.
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Major functions of the last cluster (Chronic)w e r e
related to “repair processes” such as “cellular response
to stress”, “response to radiation” and “DNA repair”.
Discriminant power of DEPs for HIV-1 stages
To directly investigate the discriminant power of DEPs
for the HIV-1 stages, we compared the prediction per-
formance of the identified DEPs with that of the DEGs
using several well-known classification methods includ-
ing a decision tree, a support vector machine, and an
artificial neural network (Methods). We here used a
LOOCV approach with several performance measures
including accuracy, sensitivity, and specificity. As shown
in Figure 5A, the prediction accuracies (95%, 100%, and
100%, respectively) of DEPs were much higher than
those (45%, 62.5%, and 70%, respectively) of DEGs
regardless of the classification method used. The better
performance of DEPs was also observed with other mea-
sures including sensitivity and specificity (Figure 5B).
Moreover, among the misclassification cases, the 71.4%
incorrect prediction (35 among 49 wrong predictions) of
the three models built with DEGs was caused by mis-
classification between Acute and Chronic or between
Uninfected and Non-progressive (Figure 5C). In the case
of DEPs, however, the three models did not misclassify
Figure 5 Performance of classification models using DEPs and DEGs. (A) Accuracies of the DEP- and DEG-based models. The accuracy of all
models was estimated by the leave-one-out test. (B) Sensitivities and specificities of the DEP- and DEG-based models. (C) Confusion matrix of
DEP- and DEG-based models in (A) (UI, Uninfected; AT, Acute; NP, Non-progressive; CN, Chronic; DT, Decision tree; NN, Neural network). This matrix
shows the actual stages of samples and their predicted stages by classification methods. Each column represents a predicted stage, and each
row represents an actual stage. The count represents the result for DEGs/that for DEPs. (D) Accuracy of SVMs according to cutoff values for
selecting DEPs. (E) Accuracies according to classification models and the number of principal components used for building models. DEPs
showed higher accuracy than did DEGs regardless of the classification model or the number of used principal components.
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fied cases were misclassification of an Uninfected sample
as Chronic and an Acute sample as Uninfected.T h e
DEP-based features correctly classified the pathophysio-
logically similar HIV-1 stage pairs.
Next, we evaluated the influence of the number of
DEPs (or DEGs) on the power for discriminating the
HIV-1 stages. The performance was evaluated by a sup-
port-vector machine with various cutoff values for the
degree of significance of DEPs from 0.5 to 1.0. Here, as
many DEGs were selected as there were DEP genes. As
shown in Figure 5D, the highest accuracy was achieved
at values of 0.6 and 0.7 (100% accuracy in classifying
H I V - 1s t a g e sw i t hD E P sa n d8 2 . 5 %a c c u r a c yw i t h
DEGs). Thus, in this study, we selected 0.7 as the cutoff
value for DEP selection because it revealed the highest
level of performance with a smaller number of DEPs
and DEGs. As a result, 100 DEPs consisting of 177
genes and 177 DEGs were selected. Additionally, we
investigated the impact of the number of selected fea-
tures from PCA analysis with the selected DEPs and
DEGs. In the PCA analysis using the 177 DEGs, about
20 principal components were required to achieve the
best performance (Figure 5E). For the selected DEP
cases, however, only three principal components were
required to obtain the best performance, which was the
same accuracy as given by all components of PCA using
DEPs. This also suggests that DEP-based features have
meaningful discriminant information with respect to the
HIV-1 stages.
Discovery of HIV-1 stage-specific network modules using
DEPs
From the selected DEPs, we discovered HIV-1 stage-
specific network modules. In this analysis, we also
included genes that directly interact with the genes in
the DEPs to extend the genes in DEPs. The extended
network had 3 545 nodes representing genes, with 50
739 edges between nodes denoting PPIs including DEPs.
Using the extended network and an MCODE method
(Methods), we identified five HIV-1-related network
modules across the HIV-1 stages (Figure 6). Their net-
work scores were 51.8, 45.0, 28.5, 14.0, and 11.0, respec-
tively. Genes and interactions that composed a network
module were predefined in the module-searching phase,
but each model of a specific HIV-1 infection stage had
its own representative co-expression scores and expres-
sion levels. In network module 5, for example, the co-
expression score between CDC7 and MCM3 was nega-
tive only in the Uninfected stage. Additionally, the inter-
actions between CDC7 and MCM4 had identical signs
for the co-expression score in Uninfected and Chronic
stages or in Acute and Non-progressive stages, respec-
tively. In GO enrichment analysis (Methods), all
identified network modules were related to DNA or
RNA metabolisms. More specifically, the main func-
tional categories of the biological process of network
modules 1 and 3 were “translation,” including “transla-
tional elongation,”“ translation,” and “gene expression.”
Module 2 was related to “RNA splicing,” including
“nuclear mRNA splicing,”“ RNA splicing via transesteri-
fication reactions,” and “mRNA processing.” Module 4
was related to “mRNA, RNA, and nucleic acid trans-
port,” and module 5 was associated with “DNA metabo-
lism,” including “DNA replication” and “DNA metabolic
process.” The HIV-related network modules revealed by
network analysis using DEPs correspond with the results
of some earlier studies (see Discussion for detailed
explanation). The proposed DEP-based method, there-
fore, complemented the DEG-based approach in the
microarray expression analysis of HIV-1 infection.
Discussion
The purpose of this study was to develop a novel micro-
array data analysis method to discover the stage-specific
protein pairs in HIV-1 infection. The developed novel
method focuses on the expression co-changing patterns
between interacting protein pairs rather than on expres-
sion levels of individual genes. Note that we here only
considered known PPIs that contact physically or chemi-
cally in selecting DEPs rather than all possible pairs
among all detected genes in microarray; both because
expressions noisy and because physically or chemically
contacting pairs can share biological function and thus
their biological meaning can be easily interpreted.
Strength of our method comparing existing correlation-
based method is that it can capture a genetic signature
for a single sample. Even though one or more samples
are used for selecting representative expression level,
our method can identify a genetic signature for a new
single sample by comparing with known representative
expression level if those levels were already known by
previous study.
With this method, 100 DEPs were selected for the dis-
criminant features of HIV-1 stages. A comparison
between DEPs and DEGs revealed that DEPs more
powerfully classified the ambiguous stages of HIV-1.
This means that DEPs can provide additional informa-
tion not included in DEGs. As shown in Figure 2A, for
example, the HIV-1-related proteins HNRNPM (600.8
under Acute and 595.0 under Chronic)a n dD H X 9
(1477.7 under Acute and 1485.7 under Chronic)h a d
similar expression levels between Acute and Chronic
stages even though the variations within individual
stages were relatively large (i.e., the expression level of
DHX9 ranged from 420 to 1110 in the Chronic stage).
Thus, the previous DEG-based approach missed both
HNRNPM and DHX9 as the stage-specific genes for
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Page 11 of 14Figure 6 HIV-related network modules. Thin lines represent PPI, and thick lines denote DEPs. Nodes indicate protein, and node color denotes
expression level. Blue, yellow, and red represent increasingly higher expressions of genes. The color of the edge represents the sign of the co-
expressed score. If the sign is positive, the edge color is red, and if it is negative, blue is used. Representative modules for each stage were
created using the median value of the co-expressed score and expression level of samples in the same stage. Network module 1 of the Chronic
stage was made from 10 network modules listed in the second row.
Yoon et al. BMC Systems Biology 2011, 5(Suppl 2):S1
http://www.biomedcentral.com/1752-0509/5/S2/S1
Page 12 of 14HIV-1. However, if we consider an expression co-chan-
ging pattern, the HNRNPM and DHX9 pair selected a
significant feature of the HIV-1 stages because the co-
changing scores were consistently positive in Acute sam-
ples but consistently negative in Chronic samples. In
this respect, the DEP-based approach could well discri-
minate all four stages of HIV-1. Moreover, DEPs were
enriched in more HIV-related GO terms, such as “apop-
tosis”, which is strongly associated with the spectrum of
the progression of HIV infection. Additionally, there is
distinct difference between the DEP-based approach and
previous correlation-based network analyses [7,8]. The
biggest difference is that the DEP-based approach gener-
ates a distinct feature set with only one sample, whereas
a correlation-based network approach finds a network
feature with groups of samples under a specific condi-
tion. Thus, it is difficult to capture the characteristics of
individual samples using the previous correlation-based
network analyses. If there is a problem in predicting an
unknown or new sample and if DEG-based analysis is
unclear, then the DEP-based approach might be
applicable.
The HIV-related network modules revealed by net-
work analysis using DEPs correspond with the results of
some earlier studies. Heterogeneous nuclear ribonucleo-
proteins (hnRNPs; complexes of RNA and protein) in
modules 1 and 2 are known as HIV protein-synthesis
modulators [27]. In module 2, SF3B2 (splicing factor 3b,
subunit 2, 145 kDa) modulates viral proliferation of HIV
through interaction with Vpr (Viral Protein R) [28].
SFRS2 (serine/arginine-rich splicing factor 2) influences
the use of the HIV-1 splicing site [29]. SNRPE (small
nuclear ribonucleoprotein polypeptide E), one of the
transcription elongation complexes, assembles with HIV
Tat [30]. DHX9 (DEAH (Asp-Glu-Ala-His) box polypep-
tide 9) affects the expression of HIV-1 [31]. Further-
more, there is an association between PCF11 (PCF11,
cleavage and polyadenylation factor subunit, homolog)
and HIV-1 transcription[32]. PCBP1 (poly(rC) binding
protein 1) and YBX1 (Y-box binding protein 1) interact
with Rev protein, a key regulator of HIV-1 gene expres-
sion [33]. NUP62 (nucleoporin 62 kDa) is related to
Rev-mediated viral RNA export by interacting with eIF-
5A (eukaryotic translation-initiation factor 5A) [34]. In
contrast to NUP62, NUP155 (nucleoporin 155 kDa) is
associated with the import of HIV DNA [35]. All of
these genes were included in DEPs but not in DEGs.
From the module analysis with DEPs, it seems that
changes in DNA and RNA metabolism are crucial in the
clinical manifestations of HIV infection, and DEPs and
HIV-related network modules might have the potential
to assist in the elucidation of the pathogenesis of HIV-1
infection at the genomic and proteomic levels. However,
further studies to seek biological confirmation are
imperative to clarify the detailed roles of DEPs in speci-
fic HIV-1 stages.
Conclusions
We present a novel microarray data analysis method
based on DEP by focusing on the expression co-chan-
ging patterns between interaction pairs. The DEP based
algorithm was more powerful in classifying the ambigu-
ous stages of HIV-1 and revealed the HIV-1 stage-speci-
fic network modules. The DEP-based method might
contribute to complementation of existing DEG-based
analyses.
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